Completed
Clinical Effectiveness of Obturator Externus Muscle Injection in Chronic Pelvic Pain Patients
What is being collected
Data Collection
Collected from past medical records and data - RetrospectiveWho is being recruted
From 20 to 75 Years
+2 Eligibility Criteria
How is the trial designed
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Observational
Study Start: March 2012
Summary
Principal SponsorYonsei University
Last updated: March 1, 2013
Sourced from a government-validated database.Claim as a partner
Study start date: March 1, 2012
Actual date on which the first participant was enrolled.Obturator externus (OE) muscle has the possibility as a pain generator, considering its anatomical and functional aspects, but this muscle as a possible target for therapeutic intervention is currently understudied in pain practice.
Principal SponsorYonsei University
Last updated: March 1, 2013
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
23 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 20 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
1 inclusion criteria required to participate
1. 20-75 adults/ 2. Chronic pelvic pain patients who required the interventional procedures/ 3. patients with a localized tenderness on inferolateral side of the pubic tubercle
1 exclusion criteria prevent from participating
1. Severe cardiovascular disease /2. Coagulation abnormality /3. Patient denial
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute,
Seoul, South KoreaOpen Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, in Google MapsCompletedOne Study Center